Spectral AI Inc (MDAI)
Spectral AI, Inc. is a healthcare company focused on predictive medical diagnostics in the United States. The company’s lead product, the DeepView System, uses proprietary AI-based algorithms to assess injured tissue and help distinguish between fully damaged, partially damaged, and healthy tissue that may not be visible to the naked eye at the time of wound presentation. It also provides a binary prediction of whether a wound is likely to heal by a specified future time point, supporting clinicians in treatment decisions. In addition, Spectral AI’s technology includes MSI imaging capabilities, which use proprietary multispectral optics and sensors to capture images of injured tissue, as well as AI-Burn software. The company is headquartered in Dallas, Texas, and its common stock trades on NASDAQ under the symbol MDAI.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-MDAI
|
$2.33
|
37.6% Upside
|
Undervalued
|
$6.25
|
269.8% Upside
|
Bargain
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 18, 2026
|
-3.9x
|
-6.1x
|
3.2x
|
52.51 M
|
52.066 M
|
15.9%
|
86.6%
|
-4.7
|
—
|
87.5%
|
